Deaths from pancreatic ductal adenocarcinoma, also known as pancreatic cancer, rank
fourth among cancer-related deaths in the United States, yet the causes of pancreatic cancer …

Pancreatic ductal adenocarcinoma (PDA) is the 12th most common cancer in the United
States. As of January 7, 2016, the American Cancer Society reported that pancreatic cancer …

The term pancreatic cancer encompasses both exocrine and endocrine tumors of the
pancreas. More than 90% of pancreatic tumors originate from ductal epithelium and this …

Pancreatic cancer is one of our most lethal malignancies. Despite substantial improvements
in the survival rates for other major cancer forms, pancreatic cancer survival rates have …

I n the United States there are 28,000 to 30,300 newly diagnosed cases of pancreatic cancer
and approximately an equal number of deaths per year from pancreatic cancer. 1, 2 Ductal …

Despite tremendous gains in the molecular understanding of exocrine pancreatic cancer,
the prognosis for this disease remains very poor, largely because of delayed disease …

This review aims to outline the most up-to-date knowledge of pancreatic adenocarcinoma
risk, diagnostics, treatment and outcomes, while identifying gaps that aim to stimulate further …

This review focuses on the pathogenesis, diagnosis, staging, and treatment of pancreatic
cancer. Although much is needed to improve the still dismal outlook for patients with this …

No common malignancy is as rapidly and inevitably fatal as pancreatic ductal
adenocarcinoma (PDA). This grim fact has driven substantial research efforts into this …

Pancreatic cancer is the seventh leading cause of cancer-related deaths worldwide.
However, its toll is higher in more developed countries. Reasons for vast differences in …